Holen Sie sich die Stockscreener-App
3.67
0.00%
0.00
Vorhandelsmarkt:
3.60
-0.07
-1.91%
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
Quanterix Corp (QTRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quanterix Corp (QTRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quanterix Corp (QTRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Quanterix Corp (QTRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Quanterix Corp (QTRX) Income Statement - TradingKey
Quanterix Corp (QTRX) Cash Flow - TradingKey
QTRX|Quanterix Corp|Price:3.665|Chg%:-0.005 - TradingKey
Quanterix Corp (QTRX) Balance Sheet - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QTRX|Quanterix Corp|Price:3.670|Chg%:-0.250 - TradingKey
Quanterix Corp (QTRX) Institutional Confidence - TradingKey
Quanterix Corp (QTRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomarker Collaboration and Licensing Deals Report 2016-2026Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Yahoo Finance
Quanterix stock trades lower despite stronger revenue and margin progress - Ad-hoc-news.de
Form 4 Quanterix Corp For: 16 July By Investing.com - Investing.com Nigeria
Quanterix Corp (QTRX) CTO converts 1,558 RSUs, withholds shares for taxes - Stock Titan
Quanterix Corp (NASDAQ: QTRX) grants 141,820 RSUs to its CFO - Stock Titan
Quanterix CFO’s 141,820-Share Award Vests Over Four Years - Stock Titan
Quanterix (QTRX) Marks Key Milestones in Alzheimer's Testing Adv - GuruFocus
Anthem Blue Cross covers Quanterix Alzheimer’s blood test - Investing.com
Quanterix test found preclinical Alzheimer’s evidence in 20% of cognitively normal adults - Stock Titan
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages - Yahoo Finance
Jason F. Faessler Net Worth (2026) - GuruFocus
Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets - Yahoo Finance
Form 4 Quanterix Corp For: 9 July By Investing.com - Investing.com Nigeria
Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX) - Stock Titan
Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares - Stock Titan
TRIB, QTRX, RCON: Why these stocks are surging after-hours today - MSN
Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees - Stock Titan
QTRX Forecast — Price Target — Prediction for 2027 - TradingView
Quanterix Corp sets out growth plans, shares trade on Nasdaq - ad-hoc-news.de
Quanterix Stock Is Popping In Pre-Market: Here's Why - Sahm
Form 4 Quanterix Corp For: 23 June - Investing.com UK
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today - TradingView
Form 4 Quanterix Corp For: 23 June By Investing.com - Investing.com Nigeria
Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld - Stock Titan
Quanterix (QTRX) CFO Jason Faessler files initial Form 3 ownership - Stock Titan
QTRXQuanterix Corp Volatility & Greeks - Finviz
Quanterix Corp (QTRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quanterix (QTRX) CTO exercises 1,558 RSUs; 467 shares withheld for taxes - Stock Titan
Biotech Quanterix gives new staff 336,804 stock units over 4 years - Stock Titan
Quanterix CCO Benjamin Meadows buys $9,695 in company stock By Investing.com - Investing.com Nigeria
Quanterix (QTRX) Chief Commercial Officer buys 3,500 shares in open-market trade - Stock Titan
Quanterix (QTRX) CCO Benjamin Meadows reports options, RSUs and PSUs in Form 3 - Stock Titan
0.79%
4.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):